Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
Omsula 0.4 mg prolonged-release capsules, hard.
Pharmaceutical Form |
---|
Prolonged-release capsule, hard. White or off-white pellets are filled in the capsules with size No. 2 (about 18 mm lengthwise and 6.3 mm in external diameter), which upper part is brown opaque, lower part is buff opaque. |
Each prolonged-release capsule, hard contains 0.4 mg tamsulosin hydrochloride.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Tamsulosin |
Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow. |
List of Excipients |
---|
Capsule content: Microcrystalline cellulose Capsule shell: Yellow iron oxide (E172) |
30, 90 or 100 capsules are packed into clear or white opaque PVC/PVDC//Aluminium blisters.
The blisters are packed into folding box with a package leaflet.
Not all pack sizes may be marketed.
Gedeon Richter Plc., Gyömrői út 19-21., 1103 Budapest, Hungary
PL 04854/0134
14/12/2012
Drug | Countries | |
---|---|---|
OMSULA | Germany, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.